Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 06/14/24 07:01:00 on US and Canada Markets.
Pseudovirus in vitro neutralization data show continued neutralizing activity of VYD222 (pemivibart) against the KP.1.1 FLiRT and KP.3 SARS-CoV-2 variants, virus selections representative of current dominant strains and the most recent FLiRT-containing viruses Invivyd’s new data is...
MicroCloud Hologram Inc. (HOLO) is expected to report for Q1 2024 Cyxtera Technologies Inc. (CYXTQ) is expected to report for Q1 2024 American Virtual Cloud Technologies Inc. (AVCTQ) is expected to report for Q1 2024 AgileThought Inc. (AGILQ) is expected to report for Q1 2024 Toto...
MicroCloud Hologram Inc. (HOLO) is expected to report for Q1 2024 Cyxtera Technologies Inc. (CYXTQ) is expected to report for Q1 2024 American Virtual Cloud Technologies Inc. (AVCTQ) is expected to report for Q1 2024 AgileThought Inc. (AGILQ) is expected to report for Q1 2024 Toto...
MicroCloud Hologram Inc. (HOLO) is expected to report for Q1 2024 Cyxtera Technologies Inc. (CYXTQ) is expected to report for Q1 2024 American Virtual Cloud Technologies Inc. (AVCTQ) is expected to report for Q1 2024 AgileThought Inc. (AGILQ) is expected to report for Q1 2024 Toto...
2024-06-14 07:00:12 ET Nitin Kumar from Mizuho Securities issued a price target of $85.00 for MTDR on 2024-06-14 05:20:00. The adjusted price target was set to $85.00. At the time of the announcement, MTDR was trading at $57.09. The overall price target consensus is at $...
LONDON and NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that on June 13, 2024 Medicare issued a final Local Coverage Determination ("LCD") for the Company's kidneyintelX.dkd testing. The final LCD can be accessed at LCD - KidneyInt...
2024-06-14 07:00:10 ET Christopher Glynn from Oppenheimer issued a price target of $48.00 for B on 2024-06-14 05:19:00. The adjusted price target was set to $48.00. At the time of the announcement, B was trading at $39.19. The overall price target consensus is at $41.67 ...
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company, today announced that it entered into separate, privately negotiated exchange agreements (the “Exchange Agreements”) with certain holders of its 2.75% Convertible Senior Notes due 2027 (the...
CHICAGO, June 14, 2024 (GLOBE NEWSWIRE) -- Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI), a commercial mortgage real estate investment trust, announced that its board of directors has declared a regular quarterly cash dividend of $0.47 per share for the second quarter of 2024. The reg...
VERSABANK RECEIVES FINAL U.S. APPROVAL FOR U.S. BANK ACQUISITON PR Newswire – Acquisition Will Enable VersaBank to Broadly Launch its Unique and Highly Successful Receivable Purchase Program Financing Solution in the United States – LONDO...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
7.06%Change Percent:
Biogen Inc. Company Name:
BIIB Stock Symbol:
NASDAQ Market:
biogen.com Website: